Yuki Miyai

3PUBLICATIONS
12CO-AUTHORS
Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jul 15, 2026
Local, but not circulating, complement C3 shapes immune checkpoint blockade efficacy by controlling myeloid cell infiltration.

|Mar 03, 2022
Meflin-positive cancer-associated fibroblasts enhance tumor response to immune checkpoint blockade.

Yuki Miyai, Daisuke Sugiyama, Tetsunari Hase

|Feb 16, 2020
Cancer-associated fibroblasts that restrain cancer progression: Hypotheses and perspectives.

Yuki Miyai, Nobutoshi Esaki, Masahide Takahashi

Pageof 1

Frequent Collaborators

3 joint publications

Atsushi Enomoto

2 joint publications

Yukihiro Shiraki

1 joint publications

Tetsunari Hase

1 joint publications

Kazuki Nishida